Delivery Order SPE2DB24D1205-SPE2DB25FDAKG
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $64K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,454.88 under a firm fixed-price contract. This delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The award was competitively awarded without set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a $23.6K delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 MG/2 ML syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA, leveraging the company's position as a critical distributor of medical products for federal healthcare systems. The award carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $3,962.99 and an ultimate completion date of September 10, 2025. Euflexxa is a viscosupplement injection used to treat knee osteoarthritis pain. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes with a ceiling value of $3,670.26. EUFLEXXA is a hyaluronic acid-based injectable treatment used for knee osteoarthritis pain management. This competitive delivery order, executed under firm fixed pricing, represents a continuation of the federal medical procurement relationship between the prime contractor and the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The award has a ceiling value of $6,113.56 and an ultimate completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order valued at $5,342.85 to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 ml syringes on September 11, 2025, with completion scheduled for September 12, 2025. EUFLEXXA is a hyaluronic acid-based injectable treatment commonly used for knee osteoarthritis pain management. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes in 2 ml quantities. This is a firm fixed price delivery order with a ceiling value of $2,575.50 and an ultimate completion date of July 30, 2025. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. EUFLEXXA is a viscosupplementation...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML syringes. The $8,961.84 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) that the company holds with DLA Troop Support Medical to supply pharmaceuticals and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract has a potential value of $8,961.84 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,365.78 firm fixed-price delivery order is for EUFLEXXA 20MG/2ML 3S medical supplies. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...